-
Tegmine Therapeutics 0 Open PositionsOur vision is to restore hope and health for patients diagnosed with untreatable cancers. There have been great advances in cancer therapeutics, but there’s....
-
Tecan Genomics 0 Open PositionsTecan Genomics, Inc. (formerly NuGEN Technologies), a part of the Tecan Group (www.tecan.com) since September 2018, is a provider of innovative genomics sample preparation....
-
Tallac Therapeutics 0 Open PositionsTallac Therapeutics is a privately held biopharmaceutical company harnessing the power of innate and adaptive immunity to fight cancer. Tallac’s pipeline of immunotherapy candidates....
-
Talis Biomedical 0 Open PositionsTalis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings. Our visionary team....
-
Synthego Corporation 0 Open PositionsSynthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health. The company....
-
Syncopation Life Sciences 0 Open PositionsSyncopation Life Sciences is advancing a new generation of adoptive cell therapies for cancers, with a new focused emphasis on addressing primary mechanisms of....
-
Strateos 0 Open PositionsStrateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create....
-
StemExpress 0 Open PositionsStemExpress supports cell and gene therapies, commercialization of disease specific treatments, medical research, clinical trials, precision/regenerative medicine, among other researchers and clinicians around the....
-
Staidson Biopharma 0 Open PositionsStaidson Biopharma Inc is a fast growing and expanding biopharmaceutical company, located in San Francisco bay area. The company is dedicated to developing novel....
-
Spotlight Therapeutics 0 Open PositionsSpotlight Therapeutics is a venture funded early-stage biotechnology company with a mission to develop a new class of therapeutics by enabling direct in vivo....